British Columbia Investment Management Corp Gilead Sciences, Inc. Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

A detailed history of British Columbia Investment Management Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 207,875 shares of GILD stock, worth $18.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

207,875

Previous 238,870 12.98%

Holding current value

$18.7 Million

Previous $16.4 Million 6.32%

% of portfolio

0.11%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $2.06 Million - $2.6 Million	-30,995 Reduced 12.98%	207,875 $17.4 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $5.66 Million - $6.53 Million	89,632 Added 60.06%	238,870 $16.4 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $415,808 - $507,067	5,809 Added 4.05%	149,238 $10.9 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $2.2 Million - $2.49 Million	30,021 Added 26.47%	143,429 $11.6 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $41,776 - $45,578	565 Added 0.5%	113,408 $8.5 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $69,093 - $78,810	909 Added 0.81%	112,843 $8.7 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $55,044 - $62,712	712 Added 0.64%	111,934 $9.29 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $802,556 - $1.15 Million	-12,878 Reduced 10.38%	111,222 $9.55 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $1.27 Million - $1.46 Million	-21,405 Reduced 14.71%	124,100 $7.66 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $2.78 Million - $3.13 Million	-48,150 Reduced 24.86%	145,505 $8.99 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $1.56 Million - $1.96 Million	-26,962 Reduced 12.22%	193,655 $11.5 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $731,392 - $830,143	-11,273 Reduced 4.86%	220,617 $16 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $52,121 - $56,233	-770 Reduced 0.33%	231,890 $16.2 Million
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $1.72 Million - $1.88 Million	27,111 Added 13.19%	232,660 $16 Million
Q1 2021 Apr 30, 2021	SELL	$60.0 - $68.46 $391,620 - $446,838	-6,527 Reduced 3.08%	205,549 $13.3 Million
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $325,171 - $370,517	-5,740 Reduced 2.64%	212,076 $12.4 Million
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $951,558 - $1.2 Million	15,323 Added 7.57%	217,816 $13.8 Million
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $4.63 Million - $5.37 Million	63,979 Added 46.19%	202,493 $15.6 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $10 Million - $12.9 Million	-160,336 Reduced 53.65%	138,514 $10.4 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $1.13 Million - $1.24 Million	-18,276 Reduced 5.76%	298,850 $19.4 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $4.43 Million - $4.89 Million	-70,874 Reduced 18.27%	317,126 $20.1 Million
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $134,134 - $150,415	-2,168 Reduced 0.56%	388,000 $26.2 Million
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $6.44 Million - $7.21 Million	-102,963 Reduced 20.88%	390,168 $25.4 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $1.77 Million - $2.3 Million	29,176 Added 6.29%	493,131 $30.8 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $10.5 Million - $11.6 Million	-147,341 Reduced 24.1%	463,955 $35.8 Million
Q2 2018 Aug 09, 2018	SELL	$64.88 - $75.68 $7.37 Million - $8.6 Million	-113,633 Reduced 15.68%	611,296 $43.3 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $1.25 Million - $1.52 Million	-17,119 Reduced 2.31%	724,929 $54.7 Million
Q4 2017 Feb 20, 2018	BUY	$71.15 - $83.52 $1.69 Million - $1.98 Million	23,719 Added 3.3%	742,048 $53.2 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $51.8 Million - $61.4 Million	718,329	718,329 $58.2 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account

British Columbia Investment Management Corp Gilead Sciences, Inc. Transaction History